PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28723334
OWN - NLM
STAT- MEDLINE
DA  - 20170720
DCOM- 20170801
LR  - 20170801
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 3
DP  - 2017 Jul 20
TI  - ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.
PG  - 296-297
LID - 10.1056/NEJMc1705994 [doi]
FAU - Gaudet, Daniel
AU  - Gaudet D
AD  - Universite de Montreal, Chicoutimi, QC, Canada.
FAU - Gipe, Daniel A
AU  - Gipe DA
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Pordy, Robert
AU  - Pordy R
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Ahmad, Zahid
AU  - Ahmad Z
AD  - University of Texas Southwestern Medical Center, Dallas, TX.
FAU - Cuchel, Marina
AU  - Cuchel M
AD  - Perelman School of Medicine of University of Pennsylvania, Philadelphia, PA.
FAU - Shah, Prediman K
AU  - Shah PK
AD  - Cedars-Sinai Heart Institute, Los Angeles, CA.
FAU - Chyu, Kuang-Yuh
AU  - Chyu KY
AD  - Cedars-Sinai Heart Institute, Los Angeles, CA.
FAU - Sasiela, William J
AU  - Sasiela WJ
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Chan, Kuo-Chen
AU  - Chan KC
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Brisson, Diane
AU  - Brisson D
AD  - Universite de Montreal, Chicoutimi, QC, Canada.
FAU - Khoury, Etienne
AU  - Khoury E
AD  - Universite de Montreal, Chicoutimi, QC, Canada.
FAU - Banerjee, Poulabi
AU  - Banerjee P
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Gusarova, Viktoria
AU  - Gusarova V
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Gromada, Jesper
AU  - Gromada J
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Stahl, Neil
AU  - Stahl N
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Yancopoulos, George D
AU  - Yancopoulos GD
AD  - Regeneron Pharmaceuticals, Tarrytown, NY.
FAU - Hovingh, G Kees
AU  - Hovingh GK
AD  - University of Amsterdam, Amsterdam, the Netherlands.
LA  - eng
PT  - Clinical Trial
PT  - Letter
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (ANGPTL3 protein, human)
RN  - 0 (Angiopoietins)
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Cholesterol, LDL)
RN  - 0 (Receptors, LDL)
RN  - 0 (evinacumab)
SB  - AIM
SB  - IM
MH  - Angiopoietins/*antagonists & inhibitors
MH  - Antibodies, Monoclonal/*therapeutic use
MH  - Cholesterol, LDL/*blood
MH  - Genotype
MH  - Humans
MH  - Hyperlipoproteinemia Type II/blood/*drug therapy/genetics
MH  - Receptors, LDL/drug effects/genetics/metabolism
EDAT- 2017/07/21 06:00
MHDA- 2017/08/02 06:00
CRDT- 2017/07/21 06:00
AID - 10.1056/NEJMc1705994 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Jul 20;377(3):296-297. doi: 10.1056/NEJMc1705994.